28th Annual European Society of Gene and Cell Therapy (ESGCT)

ESGCT will be held on October 19-22, 2021, virtually

In collaboration with Cellectis, Professor Toni Cathomen's team of the University of Freiburg, Germany, will present two oral presentations:

• Viviane Dettmer Monaco, University of Freiburg, will present the abstract Preclinical development of a TALEN based genome editing in T cells for the treatment of Hyper-IgE- Syndrome on October 20, 9-11AM CET
• Manuel Rhiel, Freiburg University, will present the abstract Preclinical development of a TALEN based genome editing therapy for RAG1 deficiency, on October 21, 9-11AM CET

Both presentations can be found on ESGCT website here: https://www.esgct.eu/